ArticleJournal of Alzheimer's disease reports
Cognitive reserve as a predictor of cognitive decline, but not age of diagnosis in patients with possible young-onset Alzheimer's disease: An underexplored population.
Article in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Outcome-specific risk factors challenge universal dementia prevention priorities: Findings from the Egyptian Dementia Network Registry.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Why some minds bend, not break: an exploratory study of cognitive and psychological performance across levels of cognitive reserve in subjective cognitive decline.Frontiers in psychology · 2026Article
- Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.AIMS neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The cognitive reserve (CR) theory aims to explain the disparity often observed between brain damage and its clinical manifestation. Objective: To explore the CR theory in young-onset Alzheimer's disease (YOAD), a population not previously investigated in this context. The goal is to assess whether, similar to late-onset Alzheimer's disease (LOAD), a high CR delays diagnosis but may accelerate cognitive decline. Methods: This is a retrospective study including 72 patients (ages: 46-64) who were diagnosed with possible YOAD. They were followed up for three years, using the Mini-Mental State Examination. Results: Unlike the findings with LOAD, age of diagnosis of the YOAD did not correlate significantly with CR variables, years of education or family size. However, years of education predicted greater cognitive decline in the first year, and women showed increased deterioration. Family size showed inconsistent associations, highlighting its limitations. Conclusions: In contrast to studies among LOAD, there was no significant correlation between age of diagnosis and CR among YOAD, suggesting that other mechanisms might be more influential than CR parameters in younger individuals. However, similar to LOAD, YOAD patients with higher education experienced faster disease progression, implying that diagnoses are frequently made when brain pathology is already severe. These findings reinforce the growing perspective that YOAD and LOAD may constitute distinct forms of AD, each with unique clinical and pathological features. They also underscore the urgent need for early detection tools and cognitive interventions to ease the challenges faced by these young patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.